Department of Health and Human Services

Part 1. Overview Information

Participating Organization(s)

National Institutes of Health (NIH)

Components of Participating Organizations

National Human Genome Research Institute (NHGRI)

Funding Opportunity Title
NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed)
Activity Code

U24 Resource-Related Research Projects – Cooperative Agreements

Announcement Type
Reissue of RFA-HG-24-006
Related Notices
  • August 31, 2022- Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.
  • August 5, 2022- Implementation Details for the NIH Data Management and Sharing Policy. See Notice NOT-OD-22-189.
Funding Opportunity Number (FON)
RFA-HG-24-013
Companion Funding Opportunity
None
Number of Applications

See Section III. 3. Additional Information on Eligibility.

Assistance Listing Number(s)
93.172
Funding Opportunity Purpose

This Notice of Funding Opportunity (NOFO) encourages applications for the NHGRI Technology Development Coordinating Center. The Coordinating Center will expand and support an infrastructure for enhancing and advancing efforts supported by NHGRI’s Genome Technology Program. The Center’s activities will include facilitating opportunities for new research collaborations to advance technology development and dissemination. The Center will also develop outreach strategies and resources to engage the broader biomedical research community and provide an Opportunity Funds Program to support innovative small-scale work.

This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation.  Applications that fail to include a PEDP will be considered incomplete and will be withdrawn.

Applicants are strongly encouraged to read the NOFO instructions carefully and view the available PEDP guidance material.

Key Dates

Posted Date
January 12, 2024
Open Date (Earliest Submission Date)
March 01, 2024
Letter of Intent Due Date(s)

March 01, 2024

Application Due Dates Review and Award Cycles
New Renewal / Resubmission / Revision (as allowed) AIDS - New/Renewal/Resubmission/Revision, as allowed Scientific Merit Review Advisory Council Review Earliest Start Date
April 02, 2024 April 02, 2024 Not Applicable July 2024 October 2024 December 2024

All applications are due by 5:00 PM local time of applicant organization. 

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

No late applications will be accepted for this Notice of Funding Opportunity (NOFO).

Expiration Date
April 03, 2024
Due Dates for E.O. 12372

Not Applicable

Required Application Instructions

It is critical that applicants follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide, except where instructed to do otherwise (in this NOFO or in a Notice from NIH Guide for Grants and Contracts).

Conformance to all requirements (both in the Application Guide and the NOFO) is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions.

Applications that do not comply with these instructions may be delayed or not accepted for review.

Table of Contents

Part 2. Full Text of Announcement

Section I. Notice of Funding Opportunity Description

Purpose

The purpose of this Notice of Funding Opportunity (NOFO) is to encourage applications for the NHGRI Technology Development Coordinating Center. The Coordinating Center will expand and support an infrastructure for enhancing and advancing efforts supported by NHGRI’s Genome Technology Program (GTP). The Center’s activities will include facilitating opportunities for new research collaborations to advance technology development and dissemination. The Center will also develop outreach strategies and resources to engage the broader biomedical research community and provide an Opportunity Funds Program to support innovative small-scale work. Through these activities, the Coordinating Center will continue to enhance integration between components of the NHGRI GTP and outreach to the broader community. The Center will be expected to work collaboratively with NHGRI-funded technology development recipients and NHGRI staff, as well as with other investigators and programs with interests in alignment with the GTP. 

Background

As highlighted in the NHGRI 2020 Strategic Vision, advancing technology development is one of the key elements needed for sustaining and improving a robust foundation for genomics. The NHGRI Genome Technology Program (GTP) aims to accelerate innovation, development, and early dissemination of genomic technologies to advance basic and clinical research into human biology and disease. Over the past 20 years, the GTP has expanded from a focused investment on advancing nucleic acid sequencing to more broadly encompassing a wide set of initiatives including those supporting technologies to advance our understanding of gene regulation and genomic function, technologies to synthesize nucleic acids, and refinement of sequencing technologies for improved resolution at the single molecule level.

The Coordinating Center was launched in 2021 and is an integral component of the GTP. It was developed to enable opportunities for collaborations among technology development recipients, improve dissemination of technology advances and resources, and accelerate technology innovation. The Center enables closer interactions between the different technology development research areas that make up the GTP. These include research projects (R01 and R21) and small business awards (R43 and R44) that are funded in response to targeted initiatives. NHGRI also supports investigator-initiated technology development projects that come in through NIH parent announcements. These grants are invited into the GTP and encouraged to participate in the Coordinating Center's activities. Active and completed NHGRI GTP grants are listed here. Additionally, the NHGRI Centers of Excellence in Genomic Science (CEGS) Program has an ongoing focus on technology development that enables crosstalk and coordination between the CEGS Program and GTP. The Coordinating Center shares information about funded grants, supported technologies, publications, and resources through a publicly accessible website.

Applicants to this NOFO are encouraged to visit the websites for the GTPCEGS, and the Coordinating Center for more information about NHGRI funding opportunities and funded activities in these areas. For the purpose of this NOFO, the Center’s responsibilities will primarily be for the GTP unless stated otherwise. 

Research Objectives

NHGRI seeks to fund a Coordinating Center that will expand the support and coordination of technology development efforts funded by NHGRI. The goal is to accelerate technology development and progress in the field of genomics. Varied expertise is required, especially prior experience in coordinating large and complex multidisciplinary collaborative research efforts and appropriate expertise in the scientific areas covered by the GTP. The Coordinating Center’s objectives are outlined as follows:

Facilitate Opportunities for New Research Collaborations

  • The Coordinating Center will organize two annual 2-3-day investigator meetings per year - one for NHGRI's GTP and one for the NHGRI CEGS program – and conferences, as appropriate. Attendance of annual meetings by the respective program recipients is required. Annual meetings for both programs are expected to serve as venues to facilitate sharing of research findings, promote the exchange of ideas, and enable discussion of opportunities, challenges, and emerging needs in genomic technology development. They also serve as opportunities for trainees to learn about careers in science through dedicated career panel discussions.
  • The Coordinating Center will convene standing scientific working groups to discuss opportunities and emerging needs in genomic technology development, as well as metrics and benchmarking approaches utilized to evaluate novel technologies. As needed, the Center will establish working groups (standing or ad hoc) around topics of interest to the genomic technology development field identified by program recipients in consultation with NHGRI staff. Groups will be composed of GTP recipients. As part of these efforts, the Coordinating Center will be expected to work with working group members to develop and organize recommendations that can be shared with the broader biomedical research community.
  • The Coordinating Center will also be responsible for mediating outreach to programs within and outside NIH that have similar interests in technology development and early dissemination as the GTP. The focus should be on developing interactions to facilitate sharing of lessons learned, best practices, and the leveraging of existing standards to enhance development and use of standards for genomic technologies.

Develop Outreach Strategies and Resources

  • The Coordinating Center will develop outreach approaches and educational materials to engage program recipients and the broader biomedical research community. This may include activities such as webinars and presentations on technologies that range from overviews of basic technology concepts to new innovations in genome-based technologies, or information pertinent to technology dissemination and adoption. This would include information about the fundamentals of intellectual property protections and identifying relevant technology applications. Materials developed should be wide-ranging to target a variety of researchers from trainees to established investigators, as well as audiences such as technology developers, functional genomics researchers, and clinical geneticists.
  • The Coordinating Center will identify opportunities to encourage and promote the NHGRI’s Small Business Program’s commercialization resources within the GTP. Commercialization is an avenue of dissemination strongly supported by NHGRI.
  • The Coordinating Center will also be responsible for maintaining a publicly accessible website for the GTP to share information such as supported technologies, resources, events, and program advances.

Support Innovative Small-scale Work

  • The Coordinating Center will manage and administer an Opportunity Funds Program to support early and innovative pilot projects in priority areas aligned with the goals of the GTP. These may include early-stage, proof-of-principle studies that could generate preliminary data for larger studies, activities to advance dissemination of methods or tools, and the development and validation of standard processes and materials that may aid new technology evaluation. The program will also enable new partnerships by encouraging collaborative projects. Funds for this program will be provided as part of the Coordinating Center and disbursed to successful applicants as approved by NHGRI. 
  • The Coordinating Center will manage solicitation of project proposals, the review process, selection of projects recommended for funding, and disbursement of funds through subawards issued to individual investigators. 
  • The Coordinating Center will also be responsible for regularly monitoring and reporting on awardee progress, expenditures, and management of the Opportunity Funds Program to NHGRI.

Plan for Enhancing Diverse Perspectives (PEDP)

This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP) as described in NOT-MH-21-310, submitted as Other Project Information as an attachment (see Section IV).

 Applicants are strongly encouraged to read the NOFO instructions carefully and view the available PEDP guidance material. The PEDP will be assessed as part of the scientific and technical peer review evaluation, as well as considered among programmatic matters with respect to funding decisions.

See Section VIII. Other Information for award authorities and regulations.

Section II. Award Information

Funding Instrument

Cooperative Agreement: A financial assistance mechanism used when there will be substantial Federal scientific or programmatic involvement. Substantial involvement means that, after award, NIH scientific or program staff will assist, guide, coordinate, or participate in project activities. See Section VI.2 for additional information about the substantial involvement for this NOFO.

Application Types Allowed
New
Renewal

The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.

Clinical Trial?

Not Allowed: Only accepting applications that do not propose clinical trials.

Funds Available and Anticipated Number of Awards

NHGRI intends to commit $1.5M Total costs/year in FY 2025 - FY 2029 to fund one award.

Award Budget

Application budgets need to reflect the actual needs of the proposed project.

Award Project Period

The maximum project period is 5 years.

NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.

Section III. Eligibility Information

1. Eligible Applicants

Eligible Organizations

Higher Education Institutions

  • Public/State Controlled Institutions of Higher Education
  • Private Institutions of Higher Education

The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:

  • Hispanic-serving Institutions
  • Historically Black Colleges and Universities (HBCUs)
  • Tribally Controlled Colleges and Universities (TCCUs)
  • Alaska Native and Native Hawaiian Serving Institutions
  • Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)

Nonprofits Other Than Institutions of Higher Education

  • Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
  • Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)

For-Profit Organizations

  • Small Businesses
  • For-Profit Organizations (Other than Small Businesses)

Local Governments

  • State Governments
  • County Governments
  • City or Township Governments
  • Special District Governments
  • Indian/Native American Tribal Governments (Federally Recognized)
  • Indian/Native American Tribal Governments (Other than Federally Recognized)

Federal Governments

  • Eligible Agencies of the Federal Government
  • U.S. Territory or Possession

Other

  • Independent School Districts
  • Public Housing Authorities/Indian Housing Authorities
  • Native American Tribal Organizations (other than Federally recognized tribal governments)
  • Faith-based or Community-based Organizations
  • Regional Organizations
Foreign Organizations

Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed. 

Required Registrations

Applicant Organizations

Applicant organizations must complete and maintain the following registrations as described in the SF 424 (R&R) Application Guide to be eligible to apply for or receive an award. All registrations must be completed prior to the application being submitted. Registration can take 6 weeks or more, so applicants should begin the registration process as soon as possible. Failure to complete registrations in advance of a due date is not a valid reason for a late submission, please reference NIH Grants Policy Statement Section 2.3.9.2 Electronically Submitted Applications for additional information

  • System for Award Management (SAM) – Applicants must complete and maintain an active registration, which requires renewal at least annually. The renewal process may require as much time as the initial registration. SAM registration includes the assignment of a Commercial and Government Entity (CAGE) Code for domestic organizations which have not already been assigned a CAGE Code.
    • NATO Commercial and Government Entity (NCAGE) Code – Foreign organizations must obtain an NCAGE code (in lieu of a CAGE code) in order to register in SAM.
    • Unique Entity Identifier (UEI) - A UEI is issued as part of the SAM.gov registration process. The same UEI must be used for all registrations, as well as on the grant application.
  • eRA Commons - Once the unique organization identifier is established, organizations can register with eRA Commons in tandem with completing their Grants.gov registrations; all registrations must be in place by time of submission. eRA Commons requires organizations to identify at least one Signing Official (SO) and at least one Program Director/Principal Investigator (PD/PI) account in order to submit an application.
  • Grants.gov – Applicants must have an active SAM registration in order to complete the Grants.gov registration.

Program Directors/Principal Investigators (PD(s)/PI(s))

All PD(s)/PI(s) must have an eRA Commons account.  PD(s)/PI(s) should work with their organizational officials to either create a new account or to affiliate their existing account with the applicant organization in eRA Commons. If the PD/PI is also the organizational Signing Official, they must have two distinct eRA Commons accounts, one for each role. Obtaining an eRA Commons account can take up to 2 weeks.

Eligible Individuals (Program Director/Principal Investigator)

Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with their organization to develop an application for support. Individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and women are always encouraged to apply for NIH support. See, Reminder: Notice of NIH's Encouragement of Applications Supporting Individuals from Underrepresented Ethnic and Racial Groups as well as Individuals with Disabilities, NOT-OD-22-019.

For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the SF424 (R&R) Application Guide.

2. Cost Sharing

This NOFO does not require cost sharing as defined in the NIH Grants Policy Statement NIH Grants Policy Statement Section 1.2 Definition of Terms.

3. Additional Information on Eligibility

Number of Applications

Applicant organizations may submit more than one application, provided that each application is scientifically distinct.

The NIH will not accept duplicate or highly overlapping applications under review at the same time, per NIH Grants Policy Statement Section 2.3.7.4 Submission of Resubmission Application. This means that the NIH will not accept:

  • A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.
  • A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
  • An application that has substantial overlap with another application pending appeal of initial peer review (see NIH Grants Policy Statement 2.3.9.4 Similar, Essentially Identical, or Identical Applications).

Section IV. Application and Submission Information

1. Requesting an Application Package

The application forms package specific to this opportunity must be accessed through ASSIST, Grants.gov Workspace or an institutional system-to-system solution. Links to apply using ASSIST or Grants.gov Workspace are available in Part 1 of this NOFO. See your administrative office for instructions if you plan to use an institutional system-to-system solution.

2. Content and Form of Application Submission

It is critical that applicants follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide except where instructed in this notice of funding opportunity to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.

Letter of Intent

Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review.

By the date listed in Part 1. Overview Information, prospective applicants are asked to submit a letter of intent that includes the following information:

  • Descriptive title of proposed activity
  • Name(s), address(es), and telephone number(s) of the PD(s)/PI(s)
  • Names of other key personnel
  • Participating institution(s)
  • Number and title of this funding opportunity

The letter of intent should be sent to:

Stephanie A. Morris
Telephone: 301-435-5738
Email: morriss2@mail.nih.gov

Page Limitations

All page limitations described in the How to Apply – Application Guide and the Table of Page Limits must be followed.

Instructions for Application Submission

The following section supplements the instructions found in the How to Apply – Application Guide and should be used for preparing an application to this NOFO.

SF424(R&R) Cover

All instructions in the SF424 (R&R) Application Guide must be followed.

SF424(R&R) Project/Performance Site Locations

All instructions in the SF424 (R&R) Application Guide must be followed.

SF424(R&R) Other Project Information

All instructions in the SF424 (R&R) Application Guide must be followed.

Other Attachments: 

Planning for Enhancing Diverse Perspectives (PEDP)

In an "Other Attachment" entitled "Plan for Enhancing Diverse Perspectives," all applicants must include a summary of strategies to advance the scientific and technical merit of the proposed project through expanded inclusivity. The PEDP should provide a holistic and integrated view of how enhancing diverse perspectives is viewed and supported throughout the application and can incorporate elements with relevance to any review criteria (significance, investigator(s), innovation, approach, and environment) as appropriate. Where possible, applicant(s) should align their description with these required elements within the research strategy section. The PEDP will vary depending on the scientific aims, expertise required, the environment and performance site(s), as well as how the project aims are structured. The PEDP may be no more than 1-page in length and should include a timeline and milestones for relevant components that will be considered as part of the review. Examples of items that advance inclusivity in research and may be part of the PEDP can include, but are not limited to:

  • Discussion of engagement with different types of institutions and organizations (e.g., research-intensive, undergraduate-focused, minority-serving, community-based).
  • Description of any planned partnerships that may enhance geographic and regional diversity.
  • Plan to enhance recruiting of women and individuals from groups historically under-represented in the biomedical, behavioral, and clinical research workforce.
  • Proposed monitoring activities to identify and measure PEDP progress benchmarks.
  • Plan to utilize the project infrastructure (i.e., research and structure) to support career-enhancing research opportunities for diverse junior, early- and mid-career researchers.
  • Description of any training and/or mentoring opportunities available to encourage participation of students, postdoctoral researchers and co-investigators from diverse backgrounds.
  • Plan to develop transdisciplinary collaboration(s) that require unique expertise and/or solicit diverse perspectives to address research question(s).
  • Publication plan that enumerates planned manuscripts and proposed lead authorship.
  • Outreach and planned engagement activities to enhance recruitment of individuals from diverse groups as research participants including those from under-represented backgrounds.

For further information on the Plan for Enhancing Diverse Perspectives (PEDP), please see https://braininitiative.nih.gov/about/plan-enhancing-diverse-perspectives-pedp.

SF424(R&R) Senior/Key Person Profile

All instructions in the SF424 (R&R) Application Guide must be followed.

Senior/Key Personnel should demonstrate scientific, administrative, technical, and management expertise consistent with the objectives of the Coordinating Center. This should include experience in facilitating collaborations, coordination of large research efforts, website design and management, and management of selection and disbursement of subawards.

The PD(s)/PI(s) must designate a dedicated Project Manager to direct the day-to-day operations of the Coordinating Center. A PD/PI may serve as the Project Manager.

R&R Budget

All instructions in the SF424 (R&R) Application Guide must be followed.

  • For single PD/PI applications, the PD/PI is expected to devote at least 3 calendar months. If multiple PDs/PIs are proposed, then each PD/PI is expected to commit sufficient time to serve their proposed role, with a minimum combined PD/PI effort of 3 calendar months. Any individual PD/PI must commit at least 1 calendar month. The appropriateness of the effort of key personnel must be justified in the budget justification. 
  • Budgets should include support for a dedicated Project Manager who will devote a minimum of 6 calendar months, to direct day-to-day operations of the Coordinating Center, coordinate across project sites, if applicable, and be responsible for promptly providing requested reporting information to NHGRI program staff. A PD/PI may serve as the Project Manager.  
  • Budget requests should include support for the GTP's annual meetings (approximately 200 participants) to cover costs for meeting facilities and logistics, and travel and accommodations for 4-6 outside speakers.
  • Budget request should include support for the CEGS program’s annual meetings (approximately 120 participants) to cover costs for meeting facilities and logistics. 
  • For all annual meetings, budgets should include costs for attendance by appropriate Coordinating Center members.
  • Budget requests for years 1-5 must include $750,000 per year to execute subawards from the Opportunity Funds program. This should be detailed in the budget for these years under F. Other Direct Costs, as the single line item "Opportunity Funds".  
  • Applicants may include allowable costs associated with PEDP implementation (as outlined in the Grants Policy Statement section 7:  https://grants.nih.gov/grants/policy/nihgps/html5/section_7/7.1_general.htm).

R&R Subaward Budget

All instructions in the SF424 (R&R) Application Guide must be followed.

PHS 398 Cover Page Supplement

All instructions in the SF424 (R&R) Application Guide must be followed.

PHS 398 Research Plan

All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions:

Research Strategy: In the Research Strategy, applicants should propose plans, approaches, and potential alternative strategies for carrying out the activities of the Coordinating Center described in the Research Objectives. The Research Strategy should consist of the following subsections. Details about what should be discussed in each section are described below.

1. Overview of the Coordinating Center

  • Provide an overview of how the Coordinating Center will be structured to facilitate the Center’s objectives and enhance technology development efforts supported by NHGRI.
  • This section should include a description of previous experience in facilitating collaborations and coordination of large, complex research efforts, appropriate expertise in technology development, as well as a description of the staffing and management structure for each objective without duplicating information in biosketches.
  • Applicants should also include their plans for collaborating with NHGRI-funded technology development recipients and NHGRI staff in the development of approaches and strategies relevant to meeting the Coordinating Center’s objectives.
  • If there are any additional responsibilities that are not detailed in the NOFO but are considered necessary for operation of the Coordinating Center, applicants should note them in this section and describe potential approaches.

2. Plans and Approaches to Facilitate Opportunities for New Research Collaborations

  • Describe plans for organizing annual investigator meetings for the GTP and CEGS program. This should include descriptions of needed logistical and operational management and considerations for in-person, virtual, and hybrid meetings.
  • Propose plans for coordinating genomic technology working groups as described in the Research Objectives. These should include strategies for consensus building, development of recommendations, and promotion of group outcomes, as well as approaches for facilitating interactions with investigators and groups outside the GTP.
  • Provide strategies and approaches for enabling communication and coordination of program activities such as establishment of teleconferencing platforms and any needed communication platforms.
  • Applicants are encouraged to propose and justify any other activities relevant to facilitating collaborations and coordinating scientifically focused discussion groups.  

3. Plans and Approaches to Develop Outreach Strategies and Resources

  • Propose and describe strategies and approaches for developing and promoting educational materials and other informational resources outlined in the Research Objectives. For example, these may include webinars, web-based tutorials, in-person presentations, and specialized sessions at GTP annual meetings or other meetings. This should also include opportunities to encourage and promote NHGRI commercialization resources within the GTP.
  • Provide plans for outreach and community engagement. This should include an overview of target audience(s) and methods.  
  • Provide a strategy for maintenance and further development of the Coordinating Center website.  
  • Where applicable, propose and justify any other activities relevant to developing outreach strategies and resources to engage program grantees and the broader biomedical research community.

4. Plans and Approaches to Provide Opportunity Funds for Promising Small-scale Work Support Innovative Small-scale Work

  • Propose and describe a management plan for the Opportunity Funds Program that includes a description of the administrative structure, process for solicitation, review, and selection of projects, recommendation process for NHGRI review and approval, procedures for funds disbursement, and plans for monitoring and reporting progress.
  • Applicants should also describe plans for interacting with the institutions of awardees and for regularly reporting on awardee progress, expenditures, and management of the Opportunity Funds Program.
  • As needed, propose and justify any other activities relevant to management of the Opportunity Funds Program that are not detailed in this section.

5. Timeline

  • Provide a detailed timeline (e.g., Gantt chart organized by month and year) of Coordinating Center activities to track progress towards each of the Center’s objectives. As part of this timeline, applicants should identify annual milestones and specific metrics that will be used to evaluate progress and effectiveness towards achievement of the Center’s objectives. Milestones and metrics may be revised at the time of award as described in the cooperative agreement terms and conditions of award.

Resource Sharing Plan: Individuals are required to comply with the instructions for the Resource Sharing Plans as provided in the SF424 (R&R) Application Guide.

The following modifications also apply:

Applicants to this NOFO should provide plans regarding the sharing needed to achieve the Coordinating Center's objectives that are not otherwise described in the Research Strategy, as appropriate and consistent with achieving the goals of the program. If not documented elsewhere, these should include plans for managing the intellectual property concerns of investigators during annual meetings, and any other opportunities in which investigators share information with the Coordinating Center.

Applicants should also include a detailed plan for how the website platform, its specific content, the backend infrastructure (e.g., software interfaces, the associated documentation), related source code, and any other Center generated resources will be received at the start of the award and continue to be rendered easily transferable to third parties or other institutions at the completion of the award period. Software or methods developed under this award should be well-documented and freely available to biomedical researchers and educators in the non-profit sector, as appropriate and consistent with achieving the goals of the Center. For a list of frequently asked questions about Best Practices for Sharing Research Software, see https://datascience.nih.gov/tools-and-analytics/best-practices-for-sharing-research-software-faq

Consistent with 45 C.F.R. 75.322, the recipient will own the data generated and software developed by the awardee, and it will be able to continue to use these data and software upon expiration or termination of the award. NIH will have unrestricted cost-free access and use of the data, resources and software generated by the recipient, including the right to transfer said data and/or software to other NIH-funded and/or managed resource projects, at the NIH's sole reasonable discretion upon termination or expiration of this award.

After initial review, NHGRI program staff will conduct an additional administrative review of the plan for resource sharing and may negotiate modifications of this plan with the prospective recipient. The final negotiated version of this plan will become a term and condition of the award.

Other Plan(s): Note: Effective for due dates on or after January 25, 2023, the Data Management and Sharing Plan will be attached in the Other Plan(s) attachment in FORMS-H application forms packages.

All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions:

  • All applicants planning research (funded or conducted in whole or in part by NIH) that results in the generation of scientific data are required to comply with the instructions for the Data Management and Sharing Plan. All applications, regardless of the amount of direct costs requested for any one year, must address a Data Management and Sharing Plan.

The following modifications also apply:

While the NIH Data Management and Sharing (DMS) Policy does not apply to development of infrastructure resources (e.g., the establishment of a website platform), other components of this award may facilitate or otherwise support research and the generation of scientific data (e.g., Opportunity Fund subawards). Therefore, please follow the NIH guidance on writing a Data Management and Sharing (DMS) Plan here, and ensure the Plan is in alignment with NHGRI’s data sharing expectations, which are summarized at genome.gov/data-sharing.

DMS Plans should address management and sharing of scientific data, including those that may be generated by subawards or research collaborations facilitated or spurred by the Coordinating Center. Applicants should ensure that data and other information produced or distributed by Center subawards or the Center follow the FAIR (Findable, Accessible, Interoperable, and Reusable) Principles.

Scientific data that need to be managed and shared per the DMS Policy may change over the course the project. If DMS Plan revisions are necessary, Plans should be updated during regular reporting intervals or sooner, with appropriate required approvals by the funding IC of any updates or revisions to the DMS Plan.

Appendix: Only limited Appendix materials are allowed. Follow all instructions for the Appendix as described in the SF424 (R&R) Application Guide.

  • No publications or other material, with the exception of blank questionnaires or blank surveys, may be included in the Appendix.

PHS Human Subjects and Clinical Trials Information

When involving human subjects research, clinical research, and/or NIH-defined clinical trials (and when applicable, clinical trials research experience) follow all instructions for the PHS Human Subjects and Clinical Trials Information form in the SF424 (R&R) Application Guide, with the following additional instructions:

If you answered “Yes” to the question “Are Human Subjects Involved?” on the R&R Other Project Information form, you must include at least one human subjects study record using the Study Record: PHS Human Subjects and Clinical Trials Information form or Delayed Onset Study record.

Study Record: PHS Human Subjects and Clinical Trials Information

All instructions in the SF424 (R&R) Application Guide must be followed.

Delayed Onset Study

Note: Delayed onset does NOT apply to a study that can be described but will not start immediately (i.e., delayed start). All instructions in the SF424 (R&R) Application Guide must be followed.

PHS Assignment Request Form

All instructions in the SF424 (R&R) Application Guide must be followed.

3. Unique Entity Identifier and System for Award Management (SAM)

See Part 1. Section III.1 for information regarding the requirement for obtaining a unique entity identifier and for completing and maintaining active registrations in System for Award Management (SAM), NATO Commercial and Government Entity (NCAGE) Code (if applicable), eRA Commons, and Grants.gov

4. Submission Dates and Times

Part I. Overview Information contains information about Key Dates and times. Applicants are encouraged to submit applications before the due date to ensure they have time to make any application corrections that might be necessary for successful submission. When a submission date falls on a weekend or Federal holiday, the application deadline is automatically extended to the next business day.

Organizations must submit applications to Grants.gov (the online portal to find and apply for grants across all Federal agencies). Applicants must then complete the submission process by tracking the status of the application in the eRA Commons, NIH’s electronic system for grants administration. NIH and Grants.gov systems check the application against many of the application instructions upon submission. Errors must be corrected and a changed/corrected application must be submitted to Grants.gov on or before the application due date and time.  If a Changed/Corrected application is submitted after the deadline, the application will be considered late. Applications that miss the due date and time are subjected to the NIH Grants Policy Statement Section 2.3.9.2 Electronically Submitted Applications.

Applicants are responsible for viewing their application before the due date in the eRA Commons to ensure accurate and successful submission.

Information on the submission process and a definition of on-time submission are provided in the How to Apply – Application Guide.

5. Intergovernmental Review (E.O. 12372)

This initiative is not subject to intergovernmental review.

6. Funding Restrictions

All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.

Pre-award costs are allowable only as described in the NIH Grants Policy Statement Section 7.9.1 Selected Items of Cost.

7. Other Submission Requirements and Information

Applications must be submitted electronically following the instructions described in the SF424 (R&R) Application Guide. Paper applications will not be accepted.

Applicants must complete all required registrations before the application due date. Section III. Eligibility Information contains information about registration.

For assistance with your electronic application or for more information on the electronic submission process, visit How to Apply – Application Guide. If you encounter a system issue beyond your control that threatens your ability to complete the submission process on-time, you must follow the Dealing with System Issues guidance. For assistance with application submission, contact the Application Submission Contacts in Section VII.

Important reminders:

All PD(s)/PI(s) must include their eRA Commons ID in the Credential field of the Senior/Key Person Profile form. Failure to register in the Commons and to include a valid PD/PI Commons ID in the credential field will prevent the successful submission of an electronic application to NIH. See Section III of this NOFO for information on registration requirements.

The applicant organization must ensure that the unique entity identifier provided on the application is the same identifier used in the organization’s profile in the eRA Commons and for the System for Award Management. Additional information may be found in the SF424 (R&R) Application Guide.

See more tips for avoiding common errors.

Applications must include annual milestones. Applications that fail to include annual milestones will be considered incomplete and will be withdrawn. Applications must include a PEDP submitted as Other Project Information as an attachment. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn before review.

Upon receipt, applications will be evaluated for completeness and compliance with application instructions by the Center for Scientific Review and responsiveness by NHGRI, NIH. Applications that are incomplete, non-compliant and/or nonresponsive will not be reviewed.

In order to expedite review, applicants are requested to notify the NHGRI Referral Office by email at jennifer.troyer@nih.gov when the application has been submitted. Please include the FON and title, PD/PI name, and title of the application.

Post Submission Materials

Applicants are required to follow the instructions for post-submission materials, as described in the policy

Any instructions provided here are in addition to the instructions in the policy.

Section V. Application Review Information

1. Criteria

Only the review criteria described below will be considered in the review process.  Applications submitted to the NIH in support of the NIH mission are evaluated for scientific and technical merit through the NIH peer review system.

For this particular NOFO, note the following:

The emphasis and priority of this NOFO are the coordination of the NHGRI GTP and the interrelated efforts that comprise this program and technology development at NHGRI. The NHGRI Technology Development Coordinating Center will be asked to organize and coordinate efforts as described in this NOFO that will enable all supported projects to accelerate technology development and progress in the field of genomics. Coordinating Center objectives are to be performed in collaboration with NHGRI staff. Accordingly, reviewers will evaluate prior experience in managing large, complex research efforts and the potential for the Coordinating Center to provide capabilities in developing the infrastructure to support program coordination and assist in achieving program goals. 

Overall Impact

Reviewers will provide an overall impact score to reflect their assessment of the likelihood for the project to exert a sustained, powerful influence on the research field(s) involved, in consideration of the following review criteria and additional review criteria (as applicable for the project proposed).

Scored Review Criteria

Reviewers will consider each of the review criteria below in the determination of scientific merit and give a separate score for each. An application does not need to be strong in all categories to be judged likely to have major scientific impact. For example, a project that by its nature is not innovative may be essential to advance a field.

 

Does the proposed Center address the needs of the technology development research program that it will serve? Is the scope of activities proposed for the Center appropriate to meet those needs? Will successful completion of the aims bring unique advantages or capabilities to the research program and genomic technology development?

Specific to this NOFO:

To what extent do the efforts described in the Plan for Enhancing Diverse Perspectives further the significance of the project?

 

Are the PD(s)/PI(s) and other personnel well suited to their roles in the Center? Do they have appropriate experience and training, and have they demonstrated experience and an ongoing record of accomplishments in managing large, complex research efforts? Do the investigators demonstrate significant experience with coordinating collaborative multidisciplinary research? If the Center is multi-PD/PI, do the investigators have complementary and integrated expertise and skills; are their leadership approach and organizational structure appropriate for the Center? Does the applicant have experience overseeing selection and management of subawards?

Specific to this NOFO:

Are sufficient expertise and effort provided to realistically manage the day-to-day operations of the Center? Where needed, are the PD(s)/PI(s) and other personnel likely to accomplish the objectives of the Center in a collaborative manner with NHGRI staff?

To what extent will the efforts described in the Plan for Enhancing Diverse Perspectives strengthen and enhance the expertise required for the project?

 

Does the application propose novel organizational concepts and management strategies in coordinating the technology development research program the Center will serve? Are the concepts and strategies, novel to one type of research program or applicable in a broad sense? Is a refinement, improvement, or new application of organizational concepts or management strategies proposed?

Specific to this NOFO:

Does the application propose novel strategies for the development of outreach strategies and informational resources?

To what extent will the efforts described in the Plan for Enhancing Diverse Perspectives meaningfully contribute to innovation?

 

Are the overall strategy, operational plan, and organizational structure well-reasoned and appropriate to accomplish the goals of the technology development research program the Center will serve? Will the investigators promote strategies to ensure a robust and unbiased scientific approach across the research program, as appropriate for the work proposed? Are potential problems, alternative strategies, and benchmarks for success presented? If the program is in the early stages of operation, does the proposed strategy adequately establish feasibility and manage the risks associated with the activities of the technology development research program? Are an appropriate plan for work-flow and a well-established timeline proposed? Have the investigators presented adequate plans to ensure consideration of relevant biological variables, such as sex, for studies of vertebrate animals or human subjects?

Specific to this NOFO:

Are the plans for accomplishing the objectives of the Center adequate and likely to be effective? How sufficient are the approaches for facilitating collaborations? Are the plans for organization and logistical management of these activities sufficient and realistic? Are the strategies for developing and promoting educational and informational resources likely to engage the broader biomedical research community and raise awareness of genomic technology development?

For the Opportunity Funds Program, is the process for application solicitation, review, recommendation, and awarding sufficiently detailed and is an adequate administrative structure proposed? Are the plans proposed for interacting with awardee institutions adequate? Is information provided on how the Center will monitor and report on awardee progress, expenditures, and management of the Opportunity Funds Program?

To what extent are the timelines, milestones, and metrics proposed for the Center well-established and appropriate for achieving the Center’s objectives?

To what extent are the timeline and milestones associated with the Plan for Enhancing Diverse Perspectives well-developed and feasible?

 

Will the institutional environment in which the Center will operate contribute to the probability of success in facilitating the technology development research program it serves? Are the institutional support, equipment and other physical resources available to the investigators adequate for the Center proposed? Will the Center benefit from unique features of the institutional environment, infrastructure, or personnel? Are resources available within the scientific environment to support electronic information handling?

Specific to this NOFO:

To what extent will features of the environment described in the Plan for Enhancing Diverse Perspectives (e.g., collaborative arrangements, geographic diversity, institutional support) contribute to the success of the project?

Additional Review Criteria

As applicable for the project proposed, reviewers will evaluate the following additional items while determining scientific and technical merit, and in providing an overall impact score, but will not give separate scores for these items.

 

For research that involves human subjects but does not involve one of the categories of research that are exempt under 45 CFR Part 46, the committee will evaluate the justification for involvement of human subjects and the proposed protections from research risk relating to their participation according to the following five review criteria: 1) risk to subjects, 2) adequacy of protection against risks, 3) potential benefits to the subjects and others, 4) importance of the knowledge to be gained, and 5) data and safety monitoring for clinical trials.

For research that involves human subjects and meets the criteria for one or more of the categories of research that are exempt under 45 CFR Part 46, the committee will evaluate: 1) the justification for the exemption, 2) human subjects involvement and characteristics, and 3) sources of materials. For additional information on review of the Human Subjects section, please refer to the Guidelines for the Review of Human Subjects.

 

When the proposed project involves human subjects and/or NIH-defined clinical research, the committee will evaluate the proposed plans for the inclusion (or exclusion) of individuals on the basis of sex/gender, race, and ethnicity, as well as the inclusion (or exclusion) of individuals of all ages (including children and older adults) to determine if it is justified in terms of the scientific goals and research strategy proposed. For additional information on review of the Inclusion section, please refer to the Guidelines for the Review of Inclusion in Clinical Research.

 

The committee will evaluate the involvement of live vertebrate animals as part of the scientific assessment according to the following three points: (1) a complete description of all proposed procedures including the species, strains, ages, sex, and total numbers of animals to be used; (2) justifications that the species is appropriate for the proposed research and why the research goals cannot be accomplished using an alternative non-animal model; and (3) interventions including analgesia, anesthesia, sedation, palliative care, and humane endpoints that will be used to limit any unavoidable discomfort, distress, pain and injury in the conduct of scientifically valuable research. Methods of euthanasia and justification for selected methods, if NOT consistent with the AVMA Guidelines for the Euthanasia of Animals, is also required but is found in a separate section of the application. For additional information on review of the Vertebrate Animals Section, please refer to the Worksheet for Review of the Vertebrate Animals Section.

 

Reviewers will assess whether materials or procedures proposed are potentially hazardous to research personnel and/or the environment, and if needed, determine whether adequate protection is proposed.

 

Not Applicable

 

For Renewals, the committee will consider the progress made in the last funding period.

 

Not Applicable

Additional Review Considerations

As applicable for the project proposed, reviewers will consider each of the following items, but will not give scores for these items, and should not consider them in providing an overall impact score.

 

Reviewers will assess whether the project presents special opportunities for furthering research programs through the use of unusual talent, resources, populations, or environmental conditions that exist in other countries and either are not readily available in the United States or augment existing U.S. resources.

Not Applicable

 

Reviewers will assess the information provided in this section of the application, including 1) the Select Agent(s) to be used in the proposed research, 2) the registration status of all entities where Select Agent(s) will be used, 3) the procedures that will be used to monitor possession use and transfer of Select Agent(s), and 4) plans for appropriate biosafety, biocontainment, and security of the Select Agent(s).

 

Reviewers will comment on whether the Resource Sharing Plan(s) (e.g., Sharing Model Organisms) or the rationale for not sharing the resources, is reasonable.

 

For projects involving key biological and/or chemical resources, reviewers will comment on the brief plans proposed for identifying and ensuring the validity of those resources.

 

Reviewers will consider whether the budget and the requested period of support are fully justified and reasonable in relation to the proposed research.

2. Review and Selection Process

Applications will be evaluated for scientific and technical merit by an appropriate Scientific Review Group convened by the National Human Genome Research Institute, in accordance with NIH peer review policies and practices, using the stated review criteria. Assignment to a Scientific Review Group will be shown in the eRA Commons.

As part of the scientific peer review, all applications will receive a written critique.

Applications may undergo a selection process in which only those applications deemed to have the highest scientific and technical merit (generally the top half of applications under review) will be discussed and assigned an overall impact score.

Appeals of initial peer review will not be accepted for applications submitted in response to this NOFO.

 Applications will compete for available funds with all other recommended applications submitted in response to this NOFO. Following initial peer review, recommended applications will receive a second level of review by the National Advisory Council for Human Genome Research. The following will be considered in making funding decisions:

  • Scientific and technical merit of the proposed Center as determined by scientific peer review.
  • Availability of funds.
  • Relevance of the proposed Center to program priorities including the PEDP.
  • Potential of the proposed Center to manage large, complex research efforts. 

3. Anticipated Announcement and Award Dates

After the peer review of the application is completed, the PD/PI will be able to access his or her Summary Statement (written critique) via the eRA Commons. Refer to Part 1 for dates for peer review, advisory council review, and earliest start date.

Information regarding the disposition of applications is available in the NIH Grants Policy Statement Section 2.4.4 Disposition of Applications.

Section VI. Award Administration Information

1. Award Notices

If the application is under consideration for funding, NIH will request "just-in-time" information from the applicant as described in the NIH Grants Policy Statement.

A formal notification in the form of a Notice of Award (NoA) will be provided to the applicant organization for successful applications. The NoA signed by the grants management officer is the authorizing document and will be sent via email to the recipient's business official.

Recipients must comply with any funding restrictions described in Section IV.6. Funding Restrictions. Selection of an application for award is not an authorization to begin performance. Any costs incurred before receipt of the NoA are at the recipient's risk. These costs may be reimbursed only to the extent considered allowable pre-award costs.

Any application awarded in response to this NOFO will be subject to terms and conditions found on the Award Conditions and Information for NIH Grants website.  This includes any recent legislation and policy applicable to awards that is highlighted on this website.

Institutional Review Board or Independent Ethics Committee Approval: Recipient institutions must ensure that protocols are reviewed by their IRB or IEC. To help ensure the safety of participants enrolled in NIH-funded studies, the recipient must provide NIH copies of documents related to all major changes in the status of ongoing protocols.

2. Administrative and National Policy Requirements

All NIH grant and cooperative agreement awards include the NIH Grants Policy Statement as part of the NoA. For these terms of award, see the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General and Part II: Terms and Conditions of NIH Grant Awards, Subpart B: Terms and Conditions for Specific Types of Grants, Recipients, and Activities, including of note, but not limited to:

If a recipient is successful and receives a Notice of Award, in accepting the award, the recipient agrees that any activities under the award are subject to all provisions currently in effect or implemented during the period of the award, other Department regulations and policies in effect at the time of the award, and applicable statutory provisions.

If a recipient receives an award, the recipient must follow all applicable nondiscrimination laws. The recipient agrees to this when registering in SAM.gov. The recipient must also submit an Assurance of Compliance (HHS-690). To learn more, see the HHS Office for Civil Rights website.

HHS recognizes that NIH research projects are often limited in scope for many reasons that are nondiscriminatory, such as the principal investigator’s scientific interest, funding limitations, recruitment requirements, and other considerations. Thus, criteria in research protocols that target or exclude certain populations are warranted where nondiscriminatory justifications establish that such criteria are appropriate with respect to the health or safety of the subjects, the scientific study design, or the purpose of the research. For additional guidance regarding how the provisions apply to NIH grant programs, please contact the Scientific/Research Contact that is identified in Section VII under Agency Contacts of this NOFO.

In accordance with the statutory provisions contained in Section 872 of the Duncan Hunter National Defense Authorization Act of Fiscal Year 2009 (Public Law 110-417), NIH awards will be subject to the Federal Awardee Performance and Integrity Information System (FAPIIS) requirements. FAPIIS requires Federal award making officials to review and consider information about an applicant in the designated integrity and performance system (currently FAPIIS) prior to making an award. An applicant, at its option, may review information in the designated integrity and performance systems accessible through FAPIIS and comment on any information about itself that a Federal agency previously entered and is currently in FAPIIS. The Federal awarding agency will consider any comments by the applicant, in addition to other information in FAPIIS, in making a judgement about the applicant’s integrity, business ethics, and record of performance under Federal awards when completing the review of risk posed by applicants as described in 2 CFR Part 200.206 “Federal awarding agency review of risk posed by applicants.” This provision will apply to all NIH grants and cooperative agreements except fellowships.

Cooperative Agreement Terms and Conditions of Award

The following special terms of award are in addition to, and not in lieu of, otherwise applicable U.S. Office of Management and Budget (OMB) administrative guidelines, U.S. Department of Health and Human Services (HHS) grant administration regulations at 2 CFR Part 200, and other HHS, PHS, and NIH grant administration policies.

The administrative and funding instrument used for this program will be the cooperative agreement, an "assistance" mechanism (rather than an "acquisition" mechanism), in which substantial NIH programmatic involvement with the recipients is anticipated during the performance of the activities. Under the cooperative agreement, the NIH purpose is to support and stimulate the recipients' activities by involvement in and otherwise working jointly with the recipients in a partnership role; it is not to assume direction, prime responsibility, or a dominant role in the activities. Consistent with this concept, the dominant role and prime responsibility resides with the recipients for the project as a whole, although specific tasks and activities may be shared among the recipients and NIH as defined below.

The PD(s)/PI(s) will have the primary responsibility for:

  • Determining research approaches, designing protocols, setting project milestones and metrics, and conducting research for carrying out the responsibilities of the Coordinating Center
  • Agreeing to accept close coordination, cooperation, and participation of NHGRI staff in the scientific and technical management of the Coordinating Center.
  • Adhering to the NHGRI policies regarding intellectual property, data release, and other policies currently established and newly established during the funding period of the Coordinating Center.
  • Collaborating with recipients  of the NHGRI Genome Technology program (GTP), NHGRI Centers of Excellence in Genomic Science (CEGS), and other NHGRI-funded genome technology development projects.
  • Coordinating, managing, and participating in annual program meetings.  
  • Leading and organizing working groups that support the discussion and exchange of ideas across the GTP.
  • Preparing and disseminating working group and program meeting minutes, as appropriate.
  • Accepting and implementing common guidelines and procedures developed for the GTP.
  • Solicitation of project proposals and organization of scientific review for the Opportunity Funds Program.
  • Management and disbursement of Opportunity Funds through subawards to individual investigators at awarded institutions.
  • Providing regular reports (reporting period to be determined in collaboration with NHGRI staff) on outreach and community engagement activities, Opportunity Funds management, and other Coordinating Center activities as determined by NHGRI staff. Any foreign collaborations included as part of working groups are the responsibility of the Coordinating Center to report to NIH. NIH reserves the right to ask individual research projects to report as well.
  • Where opportunities are identified, coordinating and collaborating with other NHGRI research programs.
  • Where opportunities are identified, coordinating and collaborating with other research programs, within and outside the NIH, that engage in genome technology development and other efforts in alignment with the GTP.
  • Data/software ownership and transition to another grantee:
    • A fundamental objective of this cooperative agreement is to ensure that the valuable data, products, and resources provided by the Coordinating Center remain available without interruption to the research community if recipient  withdraws or otherwise can no longer manage the resource or the award is terminated by the NIH.
    • Consistent with 45 C.F.R. 75.322, the recipient  will own the data generated and software developed by the awardee, and it will be able to continue to use these data and software upon expiration or termination of the award. NIH will have unrestricted cost-free access and use of the data, resources and software generated by the awardee, including the right to transfer said data and/or software to other NIH-funded and/or managed resource projects, at the NIH's sole reasonable discretion upon termination or expiration of this cooperative agreement.
    • Ownership of the data and software that may be hosted (but not created) by the Coordinating Center remains with the data and software providers.
    • Open Source Technology: Capabilities and software built as part of Coordinating Center must be delivered under an open source model. Organizations may propose to use proprietary platforms, so long as the requirements for data transparency and interoperability are maintained.
    • Recipient  will retain custody of and have primary rights to the data and software developed under these awards, subject to Government rights of access consistent with current HHS, PHS, and NIH policies. 

NIH staff have substantial programmatic involvement that is above and beyond the normal stewardship role in awards, as described below:

NIH staff designated as project scientists will have substantial programmatic involvement that is above and beyond the normal stewardship role in the conduct of the Coordinating Center's activities. However, the role of NHGRI will be to facilitate and not to direct the activities of the Coordinating Center. Specifically, the project scientist will:

  • Negotiate objectives, including timelines, milestones, and metrics, with the Coordinating Center recipient  as necessary.
  • Help coordinate collaborative research efforts that involve multiple components of the GTP and the CEGS program.
  • Assist the Coordinating Center with the development, if needed, of policies for dealing with situations that require coordinated action.
  • Provide advice on the management and technical performance of the Coordinating Center.
  • Assist in promoting informational resources and other materials developed in the course of the Coordinating Center's award to the broader biomedical research community.
  • Serve on working groups of the Genome Technology program, as appropriate.
  • Coordinate review and approval by NHGRI of recommended Opportunity Funds projects.
  • Serve as a liaison to other NIH Institutes/Centers and with groups within and outside NIH that are similarly involved in genome technology development.
  • Periodically report progress to NHGRI Leadership.

Additionally, an NHGRI Program Director will be responsible for the normal scientific and programmatic stewardship of the award and will be named in the award notice. The assigned Program Director may also serve as the NHGRI Project Scientist.

Areas of Joint Responsibility include:

  • The Coordinating Center PD(s)/PI(s) will be expected to work collaboratively with NHGRI-funded technology development grantees and NHGRI staff to develop and disseminate informational resources to the broader biomedical research community.
  • Close interactions between the Coordinating Center and participating program investigators will be required, as well as significant involvement from NIH to coordinate NHGRI technology development programs. The Coordinating Center PD(s)/PI(s), the NHGRI Project Scientist, and the NHGRI Program Director are expected to attend annual program meetings.
  • For the GTP, working groups are expected to be developed to discuss genome technologies and other topics of interest determined by program investigators. As needed, NHGRI staff will work with the Coordinating Center PD(s)/PI(s) and personnel to create working groups focused on these topics. Working groups and other Coordinating Center activities may involve participants from other NIH programs or groups outside of NIH. The Coordinating Center PD(s)/PI(s) will work collaboratively with the NHGRI Project Scientist to interact with other relevant NIH programs and groups outside NIH, as needed, to promote synergy among genome technology development efforts.
  • The NHGRI project scientist will also work with the Coordinating Center PD(s)/PI(s) to help define and prioritize research needs to be supported through the Opportunity Funds program.

Dispute Resolution:

Any disagreements that may arise in scientific or programmatic matters (within the scope of the award) between recipients and NIH may be brought to Dispute Resolution. A Dispute Resolution Panel composed of three members will be convened: a designee of the Steering Committee chosen without NIH staff voting, one NIH designee, and a third designee with expertise in the relevant area who is chosen by the other two; in the case of individual disagreement, the first member may be chosen by the individual recipient. This special dispute resolution procedure does not alter the recipient's right to appeal an adverse action that is otherwise appealable in accordance with PHS regulation 42 CFR Part 50, Subpart D and HHS regulation 45 CFR Part 16.

3. Data Management and Sharing

Consistent with the 2023 NIH Policy for Data Management and Sharing, when data management and sharing is applicable to the award, recipients will be required to adhere to the Data Management and Sharing requirements as outlined in the NIH Grants Policy Statement. Upon the approval of a Data Management and Sharing Plan, it is required for recipients to implement the plan as described.

4. Reporting

When multiple years are involved, recipients will be required to submit the Research Performance Progress Report (RPPR) annually and financial statements as required in the NIH Grants Policy Statement.

? Recipients will provide updates at least annually on implementation of the PEDP

A final RPPR, invention statement, and the expenditure data portion of the Federal Financial Report are required for closeout of an award, as described in the NIH Grants Policy Statement. NIH NOFOs outline intended research goals and objectives. Post award, NIH will review and measure performance based on the details and outcomes that are shared within the RPPR, as described at 2 CFR Part 200.301.

The Federal Funding Accountability and Transparency Act of 2006 as amended (FFATA), includes a requirement for recipients of Federal grants to report information about first-tier subawards and executive compensation under Federal assistance awards issued in FY2011 or later.  All recipients of applicable NIH grants and cooperative agreements are required to report to the Federal Subaward Reporting System (FSRS) available at www.fsrs.gov on all subawards over the threshold.  See the NIH Grants Policy Statement for additional information on this reporting requirement.

In accordance with the regulatory requirements provided at 2 CFR Part 200.113 and Appendix XII to 2 CFR Part 200, recipients that have currently active Federal grants, cooperative agreements, and procurement contracts from all Federal awarding agencies with a cumulative total value greater than $10,000,000 for any period of time during the period of performance of a Federal award, must report and maintain the currency of information reported in the System for Award Management (SAM) about civil, criminal, and administrative proceedings in connection with the award or performance of a Federal award that reached final disposition within the most recent five-year period.  The recipient must also make semiannual disclosures regarding such proceedings. Proceedings information will be made publicly available in the designated integrity and performance system (currently FAPIIS).  This is a statutory requirement under section 872 of Public Law 110-417, as amended (41 U.S.C. 2313).  As required by section 3010 of Public Law 111-212, all information posted in the designated integrity and performance system on or after April 15, 2011, except past performance reviews required for Federal procurement contracts, will be publicly available.  Full reporting requirements and procedures are found in Appendix XII to 2 CFR Part 200 – Award Term and Condition for Recipient Integrity and Performance Matters.

Section VII. Agency Contacts

We encourage inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants.

Application Submission Contacts

eRA Service Desk (Questions regarding ASSIST, eRA Commons, application errors and warnings, documenting system problems that threaten submission by the due date, and post-submission issues)

Finding Help Online: https://www.era.nih.gov/need-help (preferred method of contact)
Telephone: 301-402-7469 or 866-504-9552 (Toll Free)

General Grants Information (Questions regarding application instructions, application processes, and NIH grant resources)
Email: GrantsInfo@nih.gov (preferred method of contact)
Telephone: 301-480-7075

Grants.gov Customer Support (Questions regarding Grants.gov registration and Workspace)
Contact Center Telephone: 800-518-4726
Email: support@grants.gov

Scientific/Research Contact(s)

Stephanie A. Morris, Ph.D.
National Human Genome Research Institute (NHGRI)
Telephone: 301-435-5738
Email: morriss2@mail.nih.gov 

Peer Review Contact(s)

Rudy Pozzatti, Ph.D.
National Human Genome Research Institute (NHGRI) 
Telephone: 301-219-6235
Email: possattr@exchange.nih.gov 

Financial/Grants Management Contact(s)

Monika Christman
National Human Genome Research Institute (NHGRI)
Telephone: 301-435-7860
Email: monika.christman@nih.gov

Section VIII. Other Information

Recently issued trans-NIH policy notices may affect your application submission. A full list of policy notices published by NIH is provided in the NIH Guide for Grants and Contracts. All awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.

Authority and Regulations

Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.

NIH Office of Extramural Research Logo
Department of Health and Human Services (HHS) - Home Page
Department of Health
and Human Services (HHS)
USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.